2m 2m 2m 2m 2m 2m 2m
LANTERN PHARMA (LTRN)
NASDAQ
$2.69+$0.06 (+2.09%)
Price as of Aug 03, 2026 11:33 AM EDT- $33.6MMarket Cap
- -44.86%1-Year Change
- BiotechnologyIndustry
LANTERN PHARMA (LTRN)
$2.69+$0.06 (+2.09%)
LTRN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.63 | ||
Change | -$0.02 (-0.75%) | ||
Open | $2.72 | ||
High | $2.87 | ||
Low | $2.57 | ||
Previous Close | $2.65 | ||
Volume | 47,913 | ||
30-Day Average Volume | 130,781 | ||
1-Week Change | -4.36% | ||
1-Month Change | -36.93% | ||
1-Year Change | -44.86% | ||
3-Year Change | -43.20% | ||
5-Year Change | -79.61% | ||
Fundamentals | |||
Shares Outstanding | 12.8M | ||
Total Assets | $7.2M | ||
Market Cap | $33.6M | ||
Enterprise Value | $28.6M | ||
Period: QTR TTM FY | |||
Revenue | -$59,451.00 | ||
Net Income | -$3.4M | ||
Free Cash Flow | -$3.8M | ||
EBIT | -$3.4M | ||
EBITDA | -$3.4M | ||
Net Working Capital | $3.3M | ||
EPS | -$0.30 | ||
Enterprise Value/EBITDA | -8 | ||
Enterprise Value/Revenue | -482 | ||
P/B | N/A | ||
P/E | -9 | ||
PEG | -0 | ||
Price/Free Cash Flow | -9 | ||
Price/Operating Cash Flow | -9 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue